In Silico Design, ADMET Prediction and Molecular Docking Studies of Novel Cyanopyridine-Substituted 1,3,5-Triazine Derivatives as Potential Anti-Alzheimer Agents. MEDICARE CHURNING International Journal of Medical Science, Healthcare & Research Innovations, [S. l.], v. 1, n. 2, p. 16–39, 2026. DOI: 10.5281/zenodo.21498307. Disponível em: https://medicare.educarepublication.com/index.php/journal/article/view/19. Acesso em: 8 sep. 2026.